Cargando…
Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD
BACKGROUND: Asthma-chronic obstructive pulmonary disorder (COPD) overlap (ACO) is characterized by the coexistence of features of both asthma and COPD and is associated with rapid progress and a poor prognosis. Thus, the early recognition of ACO is crucial. OBJECTIVES: We sought to explore the plasm...
Autores principales: | Wang, Jing, Lv, Huajie, Luo, Zhuang, Mou, Shan, Liu, Jing, Liu, Chang, Deng, Shiying, Jiang, Youfan, Lin, Jiachen, Wu, Chengzhou, Liu, Xianhong, He, Jinzhi, Jiang, Depeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870925/ https://www.ncbi.nlm.nih.gov/pubmed/29580282 http://dx.doi.org/10.1186/s12931-018-0755-6 |
Ejemplares similares
-
Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study
por: Popețiu, Romana Olivia, et al.
Publicado: (2023) -
Serum YKL-40 Levels, Leukocyte Profiles, and Acute Exacerbations of Advanced COPD
por: Popețiu, Romana Olivia, et al.
Publicado: (2023) -
The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
por: Tong, Xiang, et al.
Publicado: (2018) -
Diagnostic management of inpatients with a positive D-dimer test:
developing a new clinical decision-making rule for pulmonary
embolism
por: Lei, Min, et al.
Publicado: (2021) -
Independent Predictive Value of Elevated YKL-40 in Ischemic Stroke Prognosis: Findings from a Nationwide Stroke Registry
por: Qin, Haiqiang, et al.
Publicado: (2023)